INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
SKIN
SUSTAINABILITY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
MEDIA PACK
CONTRIBUTE
Subscribe
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
SKIN
SUSTAINABILITY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
MEDIA PACK
CONTRIBUTE
SEARCH
SEARCH
advanced search
INJECTION
INJECTION
Bill Welch
PCI Pharma Services
EARLY DECISIONS, FASTER LAUNCH: OPTIMISING COMBINATION PRODUCT COMMERCIALISATION
Bill Welch explores how early development selections, structured timelines and adoption of a “path of least resistance” can reduce technical, regulatory and commercial risk, thereby optimising product commercialisation.
INJECTION
Martin Junginger
GELITA
INJECTABLE COLLAGEN – PRESENT AND FUTURE POTENTIAL
Martin Junginger discusses the advantages and challenges of delivering collagen via injection, considering the role that collagen plays in the current healthcare landscape, including GELITA's VACCIPRO
®
and MEDELLAPRO
®
collagen grades, and sharing insights on how that role may grow and adapt going forwards.
EARLY INSIGHT
Dr Scott Compel
AEMS Corp
EXCIPIENT LANDSCAPES: HIGH-THROUGHPUT SCREENING TO SOLVE VISCOSITY BOTTLENECKS FOR BIOLOGIC THERAPEUTICS
Dr Scott Compel and Dr Alex Hendricks discuss AEMS Corp's automated, microscale screening platform that enables viscosity reduction, using innovative approaches to test excipient combinations effectively.
EARLY INSIGHT
Dr Eva Littringer
Oncofuse
SCALING RADIOLIGAND THERAPY: WHY PACKAGING AND DELIVERY SYSTEMS MUST EVOLVE
Dr Eva Littringer and Dr Roland Starlinger discuss the exciting new frontier of radioligand therapy and the imminent bottleneck presented by current delivery methods running into strict limits on handling radioactive materials. They go on to introduce the Oncofuse prefilled-syringe-based system as a novel approach to containment and handling of these therapies, enabling radioligand therapy to expand beyond niche specialist clinics and hospitals.
SHOWCASE
Lifecore Injectables
CONQUERING COMPLEXITY WITH LIFECORE INJECTABLES
Lifecore Injectable, a US-based injectables CDMO, has built a reputation for embracing complex process development and manufacturing challenges that others avoid. This mindset is rooted in the company’s legacy as a manufacturer of sodium hyaluronate, a highly viscous material known for being difficult to filter and fill.
PREFILLED SYRINGES
Hervé Soukiassian
BD (Becton Dickinson & Company)
EXPANDING SUBCUTANEOUS DESIGN BRICK BY BRICK: THE BD NEOPAK™ GLASS PREFILLABLE SYRINGE PLATFORM
Hervé Soukiassian and Sophie Lelias discuss the established injection platforms built to achieve reliable and efficient subcutaneous delivery, going further to examine new injectable devices in development that are designed for an optimised patient experience as well as higher-volume, higher-viscosity delivery.
EARLY INSIGHT
Ian Speers
Pacto Medical
BEYOND THE BARREL: PREFILLED SYRINGES THAT FOLD IN HALF
Ian Speers, Robert Halvorsen and Ryan Stinebaugh discuss the unmet needs in prefilled deployability that led to the development of Slimshot™, a detached plunger rod that nests alongside the syringe, and Slimshot™ Doser, a companion concept designed to reduce the mental load of variable dosing in high-pressure delivery situations, and how these concepts can contribute to improved workflows and logistics throughout the healthcare sector.
EXPERT VIEW
Dr Mehul Desai
ANTIBODY-DRUG CONJUGATES: AN EMERGING FRONTIER IN IV TO SC CONVERSION
Dr Mehul Desai, Dr Michael Hageman and Dr Wei Chen examine the growing antibody-drug conjugate market, the unique formulation challenges these therapies present for subcutaneous delivery and how innovations in on-body injector technology may offer a practical path forwards.
EXPERT VIEW
Norbert Kübler
STERILE DRUG PRODUCTION: AN EVER-EVOLVING MARKET
Dr Norbert Kübler discusses the current state of sterile drug products, considering how advancing technology is changing the field, the role of quality control and the challenges faced during scale-up and manufacturing.
SUSTAINABILITY
Serena Grace
Owen Mumford
REAL-TIME LCAs: CREATING “A SINGLE SOURCE OF TRUTH” FOR SUSTAINABILITY
Serena Grace and Marina Dumont offer insight into the development of a real-time operational model for lifecycle assessments, and detail how organisations can transform these analyses into robust decision-making tools.
EXPERT VIEW
Henryk Badack
MAINTAINING RELIABLE DRUG DELIVERY THROUGH SUSTAINABLE OPERATIONS
Henryk Badack considers how a holistic approach to sustainability can enable CDMOs to implement efficient operations strategically – while introducing initiatives that address environmental, economic and social elements.
SUSTAINABILITY
Nadine Kaufmann
Ypsomed
BIO-BASED PLASTICS IN DRUG DELIVERY: FROM MATERIAL EQUIVALENCE TO SYSTEMIC DECARBONISATION
Nadine Kaufmann and Michael Schori analyse the feasibility of introducing sustainable materials within current regulatory frameworks, demonstrating this with a range of Ypsomed products and illustrating ways to further integrate sustainable principles into the value chain.
INTERVIEW
Prof Hanns-Christian Mahler
ten23 health
Exclusive Interview: Taking Sustainability Beyond Compliance
Prof Hanns-Christian Mahler engages in a wide-ranging discussion about current challenges and trends in the drug delivery industry, particularly on the topic of sustainability – it’s advantages, difficulties and why companies should aim to do more than the bare minimum required by the regulation.
SUSTAINABILITY
Dr Bernd Garska
Covestro LLC
RETHINKING DRUG DELIVERY: ENABLING RECYCLING AND MATERIAL EFFICIENCY IN HEALTHCARE
Dr Bernd Garska and Sven Schlecht highlight how single-use drug delivery devices can be re-thought to help solve the climate and environmental challenges in the healthcare sector.
SUSTAINABILITY
Lionel Maritan
ARaymond
ECO-DESIGN DRIVING NEST AND READY-TO-USE PACKAGING INNOVATION
Lionel Maritan and François Ciavatti discuss RayDyLyo
®
, an eco-designed nest developed to reduce the overall impact of ready-to-use components, reflecting on insights gained from lifecycle assessments, outlining the progress still to be made and illustrating how a pragmatic, inventive, eco-centric design approach can drive the development of packaging solutions with a measurably lower environmental footprint.
EXPERT VIEW
Greg Anderson
CHALLENGES & OPPORTUNITIES TO OPTIMISE SUSTAINABILITY IN PHARMACEUTICAL PACKAGING & COMBINATION DEVICES
Greg Anderson discusses the need to improve the sustainability and circularity of pharmaceutical packaging and drug delivery devices, looking at the challenges and providing a clear outline of the potential opportunities for improvement.
INDUSTRIALISATION
Stephen Gilmore
Crux Product Design
Interview: Inside The Crux Technology Centre
Stephen Gilmore discusses the opportunities and capabilities unlocked by Crux’s new Technology Centre located in Bristol, UK. Mr Gilmore provides an overview of the new capabilities provided by the facility and the potential it represents to the future of the company.
OCULAR
Dr Lorna Barron
Sanner Group
THE CHALLENGES IN DEVELOPING AND MANUFACTURING CUSTOM OPHTHALMIC INJECTOR DEVICES
Dr Lorna Barron sets out the standards that must be met for effective drug delivery to the eye, characterising both old and new delivery routes that may be used to address the unique challenges of ophthalmic disease.
OCULAR
Andreas Kalitzki
Bayer AG
SHL MEDICAL AND BAYER: A COLLABORATIVE APPROACH TO ADVANCING INTRAVITREAL PAEDIATRIC DOSING
Andreas Kalitzki, Samuel Wyler and Seda Aksel explain how Bayer and SHL Medical collaborative efforts are enhancing paediatric intravitreal injections through evidence-based dosing strategies and clinically validated therapies using SHL Medical’s Micro Dosing Device technology.
OCULAR
Dr Linara Cornell
West Pharmaceutical Services
EMPOWERING VISION FOR THE FUTURE: ADVANCED CONTAINMENT SOLUTIONS FOR OPHTHALMIC APPLICATIONS
Dr Linara Cornell, Dr Manali Potnis and Dr Krishnendu Khan review the current landscape and challenges associated with delivery systems for ophthalmic applications, and how West Pharmaceutical Services plays a critical role in this specialised industry by providing high quality prefilled syringe components and systems that meet the stringent requirements for these sight-saving therapies.
VIDEO
Bart Burgess
SHL Medical
Cardiometabolic Treatments, Rare Diseases, Variable Dosing, and Quanta
Bart Burgess discusses some of the key areas for innovation in the industry, such as rare diseases and moving away from variable dosing solutions, and introduces Quanta – SHL's latest product offering.
VIDEO
Landon Goldfarb
Instron
Automated Testing to Decrease Time-To-Market
Landon Goldfarb highlights the advantages conferred by Instron's Cobot automated testing system at both the design verification and production stages of autoinjector development.
VIDEO
Steven Kaufman
Eco-inject
Sustainability, Balancing Priorities, and Bringing New Solutions to Market
Steven Kaufman discusses the return of sustainability to the centre of drug delivery conversation and how Eco-Inject's novel autoinjector brings fresh thinking to the sector.
VIDEO
John Merhige
Credence MedSystems
Dual-Chamber Syringes, New Partnerships, and Speed-to-Market Pressures Shape 2026
John Merhige outlines his key themes shaping drug delivery in 2026: new momentum from a dual-chamber syringe fill-finish collaboration, a newly announced commercial supply agreement with a major global pharma company, and growing pressure to deliver increasingly complex molecules faster and more efficiently.
Prev
1
2
3
4
5
6
…
46
Next
Top
